Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.74
Mar. 25, 2025 16:00:00- Change -0.01 (-0.57143%)
- Volume 138,419
- Today's Open 1.7773
- Previous Close 1.75
- Today's High 1.95
- Today's Low 1.68
- 52 Week High 4.3
- 52 Week Low 1.57